http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2264627-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate | 2004-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea53afae5243f53277ae1869b52c6595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dac8d6d8a1739ea2ea8fa1b40902d40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d10e5fb78c74c22f006255ce0c89480f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdd38d794f42570f702e4000f38bebde |
| publicationDate | 2005-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2264627-C1 |
| titleOfInvention | Method of predicting clinical course of chlamidia conjunctivitis |
| abstract | FIELD: ophthalmology. n SUBSTANCE: blood serum hyaluronic acid level is first determined and, when it is below 10 μg/ml by the 50 th day of disease, prediction of clinical course of Chlamidia conjunctivitis is regarded as favorable. When indicated characteristic is above 10 μg/ml, unfavorable course of disease is predicted. n EFFECT: increased prediction accuracy. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2446399-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2450271-C1 |
| priorityDate | 2004-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.